Clinical Trial Update: Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study evaluating two dose regimens of nicardipine injection in hypertensive emergency patients with end-organ damage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Emergency

Drugs mentioned

• Nicardipine (nicardipine)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Hypertension Emergency, End-organ Damage | Phase 4 | Status: COMPLETED